JPWO2019195554A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2019195554A5
JPWO2019195554A5 JP2020554078A JP2020554078A JPWO2019195554A5 JP WO2019195554 A5 JPWO2019195554 A5 JP WO2019195554A5 JP 2020554078 A JP2020554078 A JP 2020554078A JP 2020554078 A JP2020554078 A JP 2020554078A JP WO2019195554 A5 JPWO2019195554 A5 JP WO2019195554A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
formulated
administration
composition according
hct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020554078A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021520353A5 (https=
JP2021520353A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/025796 external-priority patent/WO2019195554A1/en
Publication of JP2021520353A publication Critical patent/JP2021520353A/ja
Publication of JPWO2019195554A5 publication Critical patent/JPWO2019195554A5/ja
Publication of JP2021520353A5 publication Critical patent/JP2021520353A5/ja
Pending legal-status Critical Current

Links

JP2020554078A 2018-04-04 2019-04-04 ヒト臍帯組織由来の間葉系間質細胞を使用して脳性麻痺および低酸素性虚血性脳症を処置する方法 Pending JP2021520353A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862652818P 2018-04-04 2018-04-04
US62/652,818 2018-04-04
PCT/US2019/025796 WO2019195554A1 (en) 2018-04-04 2019-04-04 Methods of treating cerebral palsy and hypoxic-ischemic encephalopathy using human umbilical cord tissue-derived mesenchymal stromal cells

Publications (3)

Publication Number Publication Date
JP2021520353A JP2021520353A (ja) 2021-08-19
JPWO2019195554A5 true JPWO2019195554A5 (https=) 2022-04-11
JP2021520353A5 JP2021520353A5 (https=) 2022-04-11

Family

ID=68101217

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020554078A Pending JP2021520353A (ja) 2018-04-04 2019-04-04 ヒト臍帯組織由来の間葉系間質細胞を使用して脳性麻痺および低酸素性虚血性脳症を処置する方法

Country Status (11)

Country Link
US (1) US20210361716A1 (https=)
EP (1) EP3773624A4 (https=)
JP (1) JP2021520353A (https=)
KR (1) KR20210021946A (https=)
CN (1) CN112236152A (https=)
AU (1) AU2019247383B2 (https=)
BR (1) BR112020020288A2 (https=)
CA (1) CA3096037A1 (https=)
IL (1) IL277732A (https=)
SG (1) SG11202009800SA (https=)
WO (1) WO2019195554A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024075676A1 (ja) * 2022-10-03 2024-04-11 キッズウェル・バイオ株式会社 脳性まひの予防又は治療剤
WO2025100424A1 (ja) * 2023-11-10 2025-05-15 国立大学法人 東京大学 急性脳症治療剤及び急性脳症の治療方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1803193A (zh) * 2005-01-13 2006-07-19 中山大学 骨髓来源的间质干细胞用于制备治疗缺氧缺血性脑性瘫痪的制剂的用途
US20070128722A1 (en) * 2005-12-05 2007-06-07 Industrial Technology Research Institute Human mesenchymal stem cells and culturing methods thereof
US20170042944A1 (en) * 2014-04-21 2017-02-16 Anthrogenesis Corporation Treatment of conditions and complications in infants
WO2016019332A1 (en) * 2014-07-29 2016-02-04 Ingeneron, Inc. Method and apparatus for recovery of umbilical cord tissue derived regenerative cells and uses thereof
WO2017144552A1 (en) * 2016-02-22 2017-08-31 Centauri Biotech. S.L. Pharmaceutical or veterinary cell compositions comprising mesenchymal stromal cells (mscs) and dimethyl sulfoxide (dmso)
JP7126703B2 (ja) * 2016-05-24 2022-08-29 国立大学法人 東京大学 臍帯由来細胞を含む脳障害の治療剤
KR101973284B1 (ko) * 2017-01-16 2019-04-29 사회복지법인 삼성생명공익재단 신생아 hie 치료용 조성물

Similar Documents

Publication Publication Date Title
Tobias Bradycardia during dexmedetomidine and therapeutic hypothermia
Martini et al. Paediatric Rheumatology Tocilizumab in Two Children with Pansclerotic Morphoea: A Hopeful Therapy for Refractory Cases
ES2180809T5 (es) Administracion de selegilina sublingual y bucal.
JPH0324447B2 (https=)
CZ284928B6 (cs) Použití riluzolu pro výrobu léčiva určeného k léčení Parkinsonovy choroby a Parkinsonových syndromů
JP2021520353A5 (https=)
WO2021050583A1 (en) Treatment of traumatic encephalopathy by fibroblasts and therapeutic adjuvants
JPWO2019195554A5 (https=)
JPH10511647A (ja) 脳腫瘍治療のためのボスウェリア酸の使用
Burchfield Medication use in neonatal resuscitation
JP2007508284A5 (https=)
Hacker et al. AZATHIOPRINE: A FORGOTTEN ALTERNATIVE FOR TREATMENT OF SEVER PSORIASIS.
Carroll et al. Chlorpromazine and promethazine in obstetrics
Neequaye et al. Failure of intrathecal antitetanus serum to improve survival in neonatal tetanus.
JP2021512061A (ja) ウリジンの全身送達のための組成物及びデバイス
Kosasa et al. Ritodrine and terbutaline compared for the treatment of preterm labor
WO2022007832A1 (zh) 组合物在治疗脑卒中的用途
Tomioka et al. In vivo antileprosy activity of the newly synthesized benzoxazinorifamycin, KRM-1648
Ford Heat stroke with mepazine therapy
Cherqui Phase 1/2 Clinical Trial of Autologous Hematopoietic Stem and Progenitor Cell Gene Therapy for Cystinosis
Lauersen et al. Midtrimester abortion induced by serial intramuscular injections of 15 (S)-15-methyl-prostaglandin E2 methyl ester
O'LEARY et al. Hyaluronidase as an adjuvant to episiotomy
Kerr Deaths from asthma
JPWO2022093724A5 (https=)
Noori et al. The use of dobutamine in the treatment of neonatal cardiovascular compromise